United Arab Emirates claims Chinese Sinopharm vaccine is 100% effective in preventing moderate and severe Covid-19
The investigational vaccine developed by China National Pharmaceutical Group, also known as Sinopharm, is 86% effective in preventing Covid-19 infection and 100% effective in preventing severe and moderate illness, officials say. United Arab Emirates health. ad Wednesday, but with few details on the trial.
The UAE Ministry of Health cited an interim review of an advanced clinical trial involving 31,000 volunteers as the source of its information, although neither they nor Sinopharm provided data from the trial to validate the findings. allegations such as the number of infected participants or the number. actually received the vaccine.
The ministry said “no serious safety issues” had been observed, although again no information on side effects was provided.
The ministry said the announcement was an “important vote of confidence by the UAE health authorities in the safety and efficacy of this vaccine.”
The ministry added that it had officially registered the vaccine at the request of the manufacturer, which it said could eventually lead to widespread authorization of the vaccine.
With no publicly available data to verify the ministry’s statements, it’s hard not to be skeptical of its optimistic outlook. At some point, especially to gain public trust, Sinopharm will have to release data from its clinical trials.
The UAE approved the Sinopharm vaccine for emergency use in September, but only for frontline workers most at risk of contracting the virus. The ministry, in the same announcement, says the vaccine has been effective in protecting this group and hopes it could pave the way for full protection of the population and responsible opening of the economy. The announcement follows several very strong weeks in the race to develop a Covid-19 vaccine. Pfizer-BioNTech and Moderna are in the approval stage, with advanced clinical trials underway with the Russian vaccine Sputnik V and the vaccine developed by AstraZeneca and the University of Oxford. The UK has already approved the Pfizer-BioNTech vaccine and has started the the largest vaccination campaign ever Tuesday.
Another Chinese vaccine, developed by Sinovac, appears to be safe and capable of eliciting a “rapid” immune response, according to results from early-stage clinical trials. published in the Lancet medical journal.